1. Prestayko, A., D’Aoust, J., Issell, B. and Crooke, S. (1979). Cisplatin (cis-diamino-dichloroplatinum II). Cancer Treat Rev 5: 17–39.
2. Goldstein, R. and Mayor G. (1983). The nephrotoxicity of cisplatin Life Sciences 32: 685–690.
3. Barnard, C., Cleare, M. and Hydes, P. (1986). Second generation anticancer platinum compounds. Chem. Brit. 22 : 1001–1004.
4. Siddik, Z., Boxall, F., Goddard, P., Barnard, C. and Harrap, K. (1984). Antitumour, Pharmacokinetic and toxicity studies with orally administered cisplatin, CBDC and CHIP. Proc Amer Assoc Cancer Res 25: 369.
5. Binks, S. and Dobrota, M. (1986). Comparative study of cisplatin toxicity and route of administration. Biochem. Soc. Trans, 14: 694–695.